Nissan Medical Industries Statistics

Total Valuation

Nissan Medical Industries has a market cap or net worth of ILS 116.54 million. The enterprise value is 413.71 million.

Market Cap	116.54M
Enterprise Value	413.71M

Important Dates

The last earnings date was Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	Dec 11, 2024

Share Statistics

Nissan Medical Industries has 9.08 million shares outstanding. The number of shares has increased by 5.25% in one year.

Current Share Class	n/a
Shares Outstanding	9.08M
Shares Change (YoY)	+5.25%
Shares Change (QoQ)	-1.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	2.71%
Float	n/a

Valuation Ratios

The trailing PE ratio is 6.27.

PE Ratio	6.27
Forward PE	n/a
PS Ratio	0.17
PB Ratio	0.48
P/TBV Ratio	0.56
P/FCF Ratio	1.86
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.56, with an EV/FCF ratio of 6.59.

EV / Earnings	21.75
EV / Sales	0.57
EV / EBITDA	4.56
EV / EBIT	6.82
EV / FCF	6.59

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.51.

Current Ratio	1.22
Quick Ratio	0.51
Debt / Equity	0.51
Debt / EBITDA	2.03
Debt / FCF	3.05
Interest Coverage	3.36

Financial Efficiency

Return on equity (ROE) is 9.64% and return on invested capital (ROIC) is 6.96%.

Return on Equity (ROE)	9.64%
Return on Assets (ROA)	5.38%
Return on Capital (ROIC)	6.96%
Revenue Per Employee	1.82M
Profits Per Employee	48,147
Employee Count	395
Asset Turnover	0.97
Inventory Turnover	4.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.83% in the last 52 weeks. The beta is -0.23, so Nissan Medical Industries's price volatility has been lower than the market average.

Beta (5Y)	-0.23
52-Week Price Change	+13.83%
50-Day Moving Average	1,497.60
200-Day Moving Average	1,471.44
Relative Strength Index (RSI)	26.49
Average Volume (20 Days)	3,019

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nissan Medical Industries had revenue of ILS 719.76 million and earned 19.02 million in profits. Earnings per share was 2.05.

Revenue	719.76M
Gross Profit	135.30M
Operating Income	64.18M
Pretax Income	40.71M
Net Income	19.02M
EBITDA	88.62M
EBIT	64.18M
Earnings Per Share (EPS)	2.05

Full Income Statement

Balance Sheet

The company has 23.49 million in cash and 191.29 million in debt, giving a net cash position of -167.80 million or -18.47 per share.

Cash & Cash Equivalents	23.49M
Total Debt	191.29M
Net Cash	-167.80M
Net Cash Per Share	-18.47
Equity (Book Value)	374.58M
Book Value Per Share	26.49
Working Capital	50.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 71.43 million and capital expenditures -8.69 million, giving a free cash flow of 62.74 million.

Operating Cash Flow	71.43M
Capital Expenditures	-8.69M
Free Cash Flow	62.74M
FCF Per Share	6.91

Full Cash Flow Statement

Margins

Gross margin is 18.80%, with operating and profit margins of 8.92% and 2.64%.

Gross Margin	18.80%
Operating Margin	8.92%
Pretax Margin	5.66%
Profit Margin	2.64%
EBITDA Margin	12.31%
EBIT Margin	8.92%
FCF Margin	8.72%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 11.47%.

Dividend Per Share	1.50
Dividend Yield	11.47%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.25%
Shareholder Yield	6.22%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nissan Medical Industries has an Altman Z-Score of 1.98. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.98
Piotroski F-Score	n/a